These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12828753)

  • 1. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study.
    Dreno B; Chosidow O; Revuz J; Moyse D;
    Br J Dermatol; 2003 Jun; 148(6):1230-6. PubMed ID: 12828753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical antifungals for seborrhoeic dermatitis.
    Okokon EO; Verbeek JH; Ruotsalainen JH; Ojo OA; Bakhoya VN
    Cochrane Database Syst Rev; 2015 May; (5):CD008138. PubMed ID: 25933684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O; Maurette C; Dupuy P
    Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo.
    Dreno B; Moyse D
    Eur J Dermatol; 2002; 12(6):549-52. PubMed ID: 12459525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lithium gluconate 8% in the treatment of seborrheic dermatitis].
    Dréno B; Blouin E; Moyse D
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):347-51. PubMed ID: 17483754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.
    Green CA; Farr PM; Shuster S
    Br J Dermatol; 1987 Feb; 116(2):217-21. PubMed ID: 2950915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.
    Buechner SA
    J Dermatolog Treat; 2014 Jun; 25(3):226-31. PubMed ID: 23557492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole.
    Carr MM; Pryce DM; Ive FA
    Br J Dermatol; 1987 Feb; 116(2):213-6. PubMed ID: 2950914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B; Ling MR; Phillips TJ
    J Drugs Dermatol; 2006; 5(7):646-50. PubMed ID: 16865870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.
    Gupta AK; Versteeg SG
    Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial.
    Scaparro E; Quadri G; Virno G; Orifici C; Milani M
    Br J Dermatol; 2001 Apr; 144(4):854-7. PubMed ID: 11298548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis.
    Pari T; Pulimood S; Jacob M; George S; Jeyaseelan L; Thomas K
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):89-90. PubMed ID: 9552768
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial.
    Peter RU; Richarz-Barthauer U
    Br J Dermatol; 1995 Mar; 132(3):441-5. PubMed ID: 7718463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis.
    Dupuy P; Maurette C; Amoric JC; Chosidow O;
    Br J Dermatol; 2001 May; 144(5):1033-7. PubMed ID: 11359393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
    Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
    Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of seborrhoeic dermatitis to ketoconazole.
    Ford GP; Farr PM; Ive FA; Shuster S
    Br J Dermatol; 1984 Nov; 111(5):603-7. PubMed ID: 6093845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.